Persistent URL of this record https://hdl.handle.net/1887/94771
In Collections
This item can be found in the following collections:
TRANSFORM STUDY: IMPACT OF DONOR TYPE ON 12-MONTH OUTCOMES OF EVEROLIMUS AND REDUCED CALCINEURIN INHIBITOR VERSUS MYCOPHENOLATE AND STANDARD CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT PATIENTS
- All authors
- Berger, S.; Sommerer, C.; Bakr, M.; Kim, M.S.; Danguilan, R.; Fijter, J. de; Henry, M.; Luo, W.L.; Bernhardt, P.; Legendre, C.
- Date
- 2017-09-30
- Journal
- Transplant International
- Volume
- 30
- Pages
- 162 - 163